Civin C I, Levine H B, Williamson A R, Schlossman S F
J Immunol. 1976 May;116(5):1400-6.
Anti-DNP antibody production in inbred strain 2 guinea pigs immunized with chemically defined DNP-oligolysines was enhanced by increasing the antigen dose or employing more potent adjuvants. However, the increase in antibody titer was not accompanied by an increase in antibody heterogeneity. Only a small number of anti-DNP antibody-producing B lymphocyte clones were triggered to produce antibody, regardless of the antigen dose or the adjuvant used for immunization or the resulting specific antibody titer. This restricted response occurred despirte the capacity of these animals to synthesize a large number of distinct anti-DNP antibodies and of DNP-oligolysines to bind all these antibodies. These observations are inconsistent with the hypothesis that adjuvant and increased antigen dose enhance antibody titer by recruitment of more diverse precursor B cells (clonal recruitment), but support the hypothesis that adjuvant and increased antigen dose act by enhancing the expansion of a restricted few B lymphocyte clones (clonal expansion).
用化学合成的二硝基苯-寡聚赖氨酸免疫近交系2豚鼠时,通过增加抗原剂量或使用更强效的佐剂可增强抗二硝基苯抗体的产生。然而,抗体滴度的增加并未伴随着抗体异质性的增加。无论抗原剂量、用于免疫的佐剂或产生的特异性抗体滴度如何,只有少数产生抗二硝基苯抗体的B淋巴细胞克隆被触发产生抗体。尽管这些动物有能力合成大量不同的抗二硝基苯抗体,且二硝基苯-寡聚赖氨酸能结合所有这些抗体,但仍出现这种受限的反应。这些观察结果与佐剂和增加抗原剂量通过募集更多不同的前体B细胞(克隆募集)来提高抗体滴度的假设不一致,但支持佐剂和增加抗原剂量通过增强少数受限B淋巴细胞克隆的扩增(克隆扩增)起作用的假设。